Omar- If you cant raise $3 mill what does that tell you? Peanut money in the Biotech world. Anyone willing to pony up that amount of money is going to want to look under the hood. What has that company done in the past to make a PE company cough up that kind of money? What success has that company had in the past? How well is the company managed? Do they have confidence in the executive team? Unless you really have your shit together it will be very difficult to raise money. If you can't raise money, how do you fund projects that are extremely expensive in order to bring technology to market. YOU CAN'T!!
"NanoLogix is discussing with domestic and international investment groups, and is seeking additional interested parties, for an investment offer of a net-revenue interest share of the N-Assay Bacteria Diagnostic and its planned associated Pretest. In exchange for an investment of up to $3 million, NanoLogix proposes a five-year 3-5% net-revenue sharing arrangement beginning with the proposed marketing rollout of the N-Assay in 2021, following planned patient studies in Houston. The funds are to be used for company expansion, development, production and marketing for the N-Assay, Pretest, and FlatPack petri plate technologies. There is no stock issuance or dilution involved with the funding proposal.
News 
Market Data 
Discover 
